Two cases of SM patients with RUNX1-RUNX1T1 positive AML treated with sequential avapritinib after allogeneic hematopoietic stem cell transplantation(allo-HSCT)were reported in Henan Cancer Hospital. This evidence concerns the gene RUNX1 and systemic mastocytosis.